SS

Srishti Shaumya

Active Director Director DIN 07473082
DIN 07473082 First appointment Apr 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Apr 2016
Shareholding value •••• Premium profile

About Srishti Shaumya

Data last updated:

Srishti Shaumya is a Director at Shreesai Hospital & Trauma Center Private Limited (since 2018), Director at Galipea Molecules Private Limited (since 2022) and Director at Ledawai Healthtech Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Healthcare, Pharma and Education & Learing. The 2 current companies with reported revenue have a combined latest revenue of ₹8.19 Cr; the largest is Shreesai Hospital & Trauma Center Private Limited at ₹7.51 Cr (FY 2025). Earlier, Srishti Shaumya was a Director at Cureinstant Technology Private Limited (2016–2019) and Director at Kushmalti Developers Private Limited (2016–2019).

DIN 07473082
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 2016
Oldest Company Age 8 yrs
Largest company Shreesai Hospital & Trauma Center Private Limited · ₹7.51 Cr (FY 2025)
Combined revenue ₹8.19 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20182018₹7.51 Cr (FY 2025)Active
Galipea Molecules Private Limited U24299DL2019PTC351484
Director18 Feb 20222019₹68.2 Lakh (FY 2024)Active
Ledawai Healthtech Private Limited U86909UP2025PTC224306
Director20 May 20252025Active
Director19 Oct 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Sep 20162016Active
Kushmalti Developers Private Limited U70100BR2016PTC031389
Director20 Apr 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Srishti Shaumya

Directorship timeline

Open interactive timeline →
Galipea Molecules Private Limited
Ss And As Health & Education Development Foundation
Shreesai Hospital & Trauma Center Private Limited
Ledawai Healthtech Private Limited
Premium access

Shareholding and investment profile for Srishti Shaumya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srishti Shaumya

Srishti Shaumya currently holds 4 directorships: Shreesai Hospital & Trauma Center Private Limited (Director, since 16 Aug 2018, revenue ₹7.51 Cr (FY 2025)); Galipea Molecules Private Limited (Director, since 18 Feb 2022, revenue ₹68.2 Lakh (FY 2024)); Ledawai Healthtech Private Limited (Director, since 20 May 2025); Ss And As Health & Education Development Foundation (Director, since 19 Oct 2022).

Srishti Shaumya was first appointed on 20 Apr 2016 as Director at Kushmalti Developers Private Limited. The most recent appointment on record is 20 May 2025 at Ledawai Healthtech Private Limited.

The 2 current companies of Srishti Shaumya that report revenue have a combined latest revenue of ₹8.19 Cr: Shreesai Hospital & Trauma Center Private Limited ₹7.51 Cr (FY 2025); Galipea Molecules Private Limited ₹68.2 Lakh (FY 2024).

Srishti Shaumya held 2 earlier board appointments: Cureinstant Technology Private Limited (Director, 02 Sep 2016 to 21 Jan 2019); Kushmalti Developers Private Limited (Director, 20 Apr 2016 to 03 Jan 2019).

The current boards of Srishti Shaumya's companies include Rameshwar Kumar (Shreesai Hospital & Trauma Center Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available